Alexander Gaber (Former)
1 – 10 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
(
- Contribution to journal › Article
- 2019
-
Mark
Expression of tSTAT3, pSTAT3
727
, and pSTAT3
705
in the epithelial cells of hormone-naïve prostate cancer
(
- Contribution to journal › Article
- 2018
-
Mark
MMP7 modulation by short- and long-term radiotherapy in patients with rectal cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
(
- Contribution to journal › Article
- 2015
-
Mark
S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.
(
- Contribution to journal › Article
-
Mark
Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis
(
- Contribution to journal › Article